Kristin Comella, Chief Scientific Officer at Bioheart Inc, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, âConducting the first trial of its kind and overcoming the challenges encountered.'
In her presentation, Kristin gives an overview on:
- Clinical development case study for MyoCell: challenges encountered and solutions for negotiating them
- Working with KOLs, regulatory authorities and advocacy groups: what is the respective involvement of each of these partners in improving clinical trials?
- Implications for the industry: what can other drug companies learn from the MyoCell story to date?
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.